| 2 April 2014 | GATA4 mutations are a cause of neonatal and childhood-onset diabetes | Shaw-Smith, C; De Franco, E; Lango Allen, H; et al. |
| 10 August 2015 | Expanding the Clinical Spectrum Associated With GLIS3 Mutations | Dimitri, P; Habeb, AM; Garbuz, F; et al. |
| 2014 | Identifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicine | Jones, AG; Shields, BM; Hyde, CJ; et al. |
| 28 December 2012 | Identifying clinical criteria to predict Type 1 diabetes, as defined by absolute insulin deficiency: a systematic review protocol. | Shields, BM; Peters, JL; Cooper, C; et al. |
| 1 September 2016 | Prematurity should not prevent genetic testing for neonatal diabetes | Besser, RE; Flanagan, SE; Mackay, DG; et al. |
| 1 October 2016 | Monogenic autoimmune diseases of the endocrine system | Johnson, MB; Hattersley, AT; Flanagan, SE |
| 28 September 2016 | Genome-wide associations for birth weight and correlations with adult disease | Horikoshi, M; Beaumont, RN; Day, FR; et al. |
| 8 April 2016 | Differential regulation of serum microRNA expression by HNF1β and HNF1α transcription factors. | Fendler, W; Madzio, J; Kozinski, K; et al. |
| 27 April 2016 | Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk. | Vedovato, N; Cliff, E; Proks, P; et al. |
| 17 August 2016 | Hypogonadotropic hypogonadism and short stature in patients with diabetes due to neurogenin 3 deficiency | Rubio-Cabezas, O; Luis Gómez, J; Gleisner, A; et al. |
